GPCC Preventive Screening Programmes
Population-Based Breast Cancer Early Detection Programme
The basic stage consists in mammography of both breasts (for each breast, images in two views are taken: oblique and craniocaudal). For women who are found at the basic stage to require further diagnosis due to any abnormalities, ultrasonography, targeted mammography, or fine- or core-needle biopsy are performed depending on doctor’s prescription.
Personal (Ground floor, Building D, room 009)
Before screening, please present: ID card and images from previous mammography. On the day of the screening, do not use any deodorants or talcum powder, as these may imitate cancerous lesions in X-ray image. Wear clothes that are easy to take off and put on again.
Population-based Cervical Cancer Early Detection Programme
Women aged 25-59 who have had no cytology smear taken within recent two years and have never benn treated for cervical cancer.
Programme of care for families at high genetic risk of cancer – Module I – Cancer prevention and early detection in families with a genetic predisposition to breast cancer and ovary cancer.
Individuals who are carriers of BRCA1 mutations and/or patients with burdened family history. Genetic test and completed questionnaire with family history are required for participation in the programme.
– Personal (ground floor, patio, Central Reception Desk),
– On-line at: https://erejestracja.wco.pl/
Programme of care for families at high genetic risk of cancer – Module II – Cancer prevention and early detection in families with a genetic predisposition to hereditary non-polyposis colorectal cancer (HNPCC), Lynch syndrome and familial adenomatous polyposis (FAP).
The programme includes patients with MMR and APC mutations and those with burdened family history. Genetic test and completed questionnaire with family history are required for participation in the programme.
– Telephone (+ 48 61 8850 557, Monday through Friday: 7:00 a.m. do 4:00 p.m.; Wednesday to 5:30 p.m.)
– Personal (ground floor, patio, Central Reception Desk),
– On-line at: https://erejestracja.wco.pl/
Registration is based on referral from a physician (e.g. general practitioner)
Programme of care for families at high genetic risk of cancer – Cancer prevention and early detection in families at high risk of colorectal cancer and endometrial cancer.
Individuals from families at high risk of olorectal cancer and endometrial cancer.
The National Head and Neck Cancer Prevention Programme – a project financed from the European Social Fund in 2017-2020
The National Head and Neck Cancer Prevention Programme is a response to a constant and highly significant growth in the incidence of head & neck cancers. That group of diseases is most often diagnosed at stage III and IV, where medicine may only offer palliative treatment aimed to prolong life and improve its quality. According to the data of the National Cancer Registry, the number of new cases has risen in the last decade by 25%, i.e. from 8,694 to 10,801. The Healthcare Maps developed by the the Ministry of Health predict a further 10% growth in H&NC incidence in 2015-2025.
The programme was developed by Prof. Wojciech Golusiński, Head of the Head & Neck Surgery and ENT Oncology Department and Clinic, Greater Poland Cancer Centre, Poznań, President of the Polish Head and Neck Cancer Society.
In the period from 1 September 2017 to 31 August 2020, the Greater Poland Cancer Centre will carry out a preventive project for early detection of head & neck cancer in the Lubuskie, Wielkopolska and West Pomeranian provinces, its main objectives being:
– to provide free secondary prevention healthcare services to a population of 7,500 (3,000 females and 4,500 males) from the project reference area. The target group will include people at a high risk of H&NC, i.e.: individuals aged 40-65, long-term smokers, abusing alcohol, exposed to increased risk of human papilloma virus infection, with one of the six symptoms not related to upper airway infection persisting for over three weeks, i.e.: burning tongue, non-healing ulceration and/or red or white lesions in the mouth, sore throat, persistent hoarse voice, nodule on the neck, nasal congestion bloody nasal drainage, pain during or trouble swallowing. The programme may also include individuals from the above age group who are not long-term smokers, do not abuse alcohol or are not exposed to high risk of human papilloma virus infection, but have shown one of the above symptoms for more than three weeks
– to raise awareness of H&NC with medical staff of primary healthcare institutions (POZs)
– to carry out an educational campaign directed to the target group about the risk factors and early symptoms of H&NC
– to implement an emotional support programme for H&NC patients, including meetings of patients and their families with psychological and social health experts
– to establish and maintain a cooperation platform between stakeholders (including POZ doctors, decision-makers, H&NC patient organisations
Study subjects will be invited in two stages:
– by POZ doctors (POZ doctors will be responsible for educating patients from their active lists and qualifying them for screening tests)
– by reporting directly to a specialist centre following educational campaigns (a questionnaire on risk factors will need to be filled out at registration)
The study of the target group will begin in 2018.
Training courses are now being prepared for doctors and a meeting is being held as part of the emotional support project for H&NC patients.